JP2016512828A5 - - Google Patents

Download PDF

Info

Publication number
JP2016512828A5
JP2016512828A5 JP2016501378A JP2016501378A JP2016512828A5 JP 2016512828 A5 JP2016512828 A5 JP 2016512828A5 JP 2016501378 A JP2016501378 A JP 2016501378A JP 2016501378 A JP2016501378 A JP 2016501378A JP 2016512828 A5 JP2016512828 A5 JP 2016512828A5
Authority
JP
Japan
Prior art keywords
composition
oil
weight
peg
polyoxyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016501378A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016512828A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/023903 external-priority patent/WO2014150660A1/en
Publication of JP2016512828A publication Critical patent/JP2016512828A/ja
Publication of JP2016512828A5 publication Critical patent/JP2016512828A5/ja
Pending legal-status Critical Current

Links

JP2016501378A 2013-03-15 2014-03-12 ラセカドトリル脂質組成物 Pending JP2016512828A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361787597P 2013-03-15 2013-03-15
US61/787,597 2013-03-15
PCT/US2014/023903 WO2014150660A1 (en) 2013-03-15 2014-03-12 Racecadotril lipid compositions

Publications (2)

Publication Number Publication Date
JP2016512828A JP2016512828A (ja) 2016-05-09
JP2016512828A5 true JP2016512828A5 (enExample) 2017-02-09

Family

ID=50628914

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016501378A Pending JP2016512828A (ja) 2013-03-15 2014-03-12 ラセカドトリル脂質組成物

Country Status (15)

Country Link
US (2) US9801819B2 (enExample)
EP (1) EP2968138B1 (enExample)
JP (1) JP2016512828A (enExample)
KR (1) KR20160101167A (enExample)
CN (1) CN105246460A (enExample)
AU (2) AU2014235733B2 (enExample)
BR (1) BR112015023387A2 (enExample)
CA (2) CA2907195A1 (enExample)
IL (1) IL241065A0 (enExample)
MX (2) MX2015012345A (enExample)
PH (1) PH12015502014A1 (enExample)
RU (2) RU2662069C2 (enExample)
SA (1) SA515361092B1 (enExample)
WO (2) WO2014150660A1 (enExample)
ZA (1) ZA201507661B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9801819B2 (en) * 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
US9114171B2 (en) * 2012-06-28 2015-08-25 Mcneil-Ppc, Inc. Racecadotril liquid compositions
HK1208177A1 (en) 2012-06-28 2016-02-26 麦克内尔-Ppc股份有限公司 Racecadotril liquid compositions
US10039712B2 (en) 2012-06-28 2018-08-07 Johnson & Johnson Consumer Inc. Racecadotril lipid compositions
US20150342882A1 (en) * 2012-06-28 2015-12-03 Johnson & Johnson Consumer Inc. Methods of treatment using cadotril compositions
CN105848643A (zh) * 2013-12-23 2016-08-10 强生消费者公司 消旋卡多曲组合物
MA46051A (fr) * 2016-08-23 2021-03-31 Johnson & Johnson Consumer Inc Nouvelle composition améliorée de racecadotril
EP3716954A1 (en) 2017-11-27 2020-10-07 Umecrine Cognition AB Pharmaceutical formulation of 3 -ethynyl-3 -hydroxyandrostan-17-one oxime
CN111867567A (zh) * 2018-02-26 2020-10-30 R·P·舍勒科技有限责任公司 二甲硅油和洛哌丁胺的乳剂的药物剂型
EP3998063A4 (en) * 2019-07-08 2023-03-15 MORESCO Corporation Compositions for preparing microemulsion, microemulsion, method for producing composition and microemulsion, and use of microemulsion
US20230398102A1 (en) * 2020-10-29 2023-12-14 Bausch Health Ireland Limited Rifaximin liquid formulations for use inthe treatment of sickle cell disease
WO2025212856A1 (en) * 2024-04-05 2025-10-09 The Board Of Regents Of The University Of Texas System Microemulsion formulations

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480747A1 (fr) 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
FR2623498B1 (fr) 1987-11-24 1990-04-06 Bioprojet Soc Civ Nouveaux composes enantiomeres derives d'amino-acides, leur procede de preparation et leurs applications therapeutiques
US5136076A (en) 1987-11-24 1992-08-04 Societe Civile Bioprojet Process for the preparation of amino acid-derived enatiomeric compounds
SE9503143D0 (sv) * 1995-09-12 1995-09-12 Astra Ab New preparation
AU1939797A (en) 1996-03-14 1997-10-01 Shionogi & Co., Ltd. Rapid-release microdispersible ecadotril preparation
CA2283780A1 (en) 1997-03-12 1998-09-17 Abbott Laboratories Lipophilic binary systems for the administration of lipophilic compounds
GB9907715D0 (en) 1999-04-01 1999-05-26 Scherer Corp R P Pharmaceutical compositions
CZ299591B6 (cs) 2000-06-23 2008-09-10 Bioprojet Suchý práškový farmaceutický prostredek pro orální podání
GB0015490D0 (en) 2000-06-23 2000-08-16 Smithkline Beecham Lab Novel formulations
EP1563848A1 (en) * 2004-02-12 2005-08-17 Bioprojet New combinations of an anti-emetic agent and an enkephalinase inhibitor
FR2900823B1 (fr) * 2006-05-15 2009-02-13 Bioprojet Soc Civ Ile Nouvelle forme d'administration du racecadotril.
CN101103960B (zh) 2006-07-14 2010-12-08 海南盛科生命科学研究院 一种含有消旋卡多曲的干混悬剂及其制备方法
CN101264065A (zh) 2008-04-18 2008-09-17 盐城苏海制药有限公司 消旋卡多曲滴丸及其制备方法
US20100330169A1 (en) 2009-06-29 2010-12-30 Frank Bunick Pharmaceutical Tablet Containing A Liquid Filled Capsule
CN102018707A (zh) * 2010-11-29 2011-04-20 昆明邦宇制药有限公司 一种治疗腹泻的药物组合物及其制剂
EP2462922A1 (en) 2010-12-10 2012-06-13 Bioprojet New form of administration of enkephalinase inhibitor
CN102133186B (zh) 2011-03-18 2012-08-01 海南美大制药有限公司 一种消旋卡多曲脂质体固体制剂
CN102327234B (zh) 2011-09-28 2017-04-12 海南康芝药业股份有限公司 一种消旋卡多曲干混悬剂
US10039712B2 (en) * 2012-06-28 2018-08-07 Johnson & Johnson Consumer Inc. Racecadotril lipid compositions
HK1208177A1 (en) 2012-06-28 2016-02-26 麦克内尔-Ppc股份有限公司 Racecadotril liquid compositions
US9114171B2 (en) 2012-06-28 2015-08-25 Mcneil-Ppc, Inc. Racecadotril liquid compositions
US9801819B2 (en) 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
US20150342882A1 (en) 2012-06-28 2015-12-03 Johnson & Johnson Consumer Inc. Methods of treatment using cadotril compositions
EP2749270B1 (en) 2012-12-26 2018-01-17 ILKO Ilaç Sanayi ve Ticaret A.S. Racecadotril and pharmaceutical compositions thereof

Similar Documents

Publication Publication Date Title
JP2016512828A5 (enExample)
RU2015144013A (ru) Липидные композиции рацекадотрила
RU2015102597A (ru) Липидные композиции рацекадотрила
JP7617927B2 (ja) 口内溶解性フィルムおよび口内溶解性フィルムを製造し、使用する方法
JP5571311B2 (ja) ブチルフタリド静脈内エマルジョン及びその適用
KR102213143B1 (ko) 지방질 화합물, 트리글리세리드 및 계면활성제를 포함하는 조성물 및 이를 이용하는 방법
JP2013508296A5 (enExample)
JP2013177454A5 (enExample)
JP6276433B2 (ja) マイクロエマルション前濃縮物及びマイクロエマルション、並びにその調製工程
GB2596184A (en) Non-aqueous solutions for oral dosage
JP2015516418A5 (enExample)
AU2015270187A1 (en) Oral pharmaceutical composition of isotretinoin
RU2013126259A (ru) Фармацевтическая композиция таксоидов
KR101767296B1 (ko) 활성제로서 페닐아미노피리미딘 유도체를 포함하는 제제
JP2014513710A5 (enExample)
JP2017500355A (ja) ラセカドトリル組成物
WO2012015969A1 (en) Compositions and methods for increased delivery of coenzyme q10
RU2021113529A (ru) Фармацевтическая композиция
HK1208178B (en) Racecadotril lipid compositions